Académique Documents
Professionnel Documents
Culture Documents
Hypertension
Disease/Condition(s)
/
Hypertension
1958WHO/
160/95 mmHg1999(WHO)
1997 (JNC)6
140/90mm Hg1993WHO
1.18
2140mm Hg/90mm Hg
2.
130mmHg80mmHg2003
JNC7120-139/80-89 mmHgprehypertension
140-159mmHg
90-99mmHg160mmHg
100mmHg()
180mmHg
110mmHg
175/85mmHg
140mmHg90mmHg
12~13 35 15~16 35
5-10mmHg
20mmHg2-4mmHg
Korotkoff
Korotkoff
DC
Guideline Category
Counseling
Evaluation
Management
Prevention
Clinical Specialty
Family Medicine
Internal Medicine
Cardiology
Gerontology
Preventive Medicine
Intended Users
()
Guideline Objective(s)
[1-3]
(disease burden)[4]
(disease burden)[4]
[1-3,5,6]
Target Population
2-4 160/110mmHg 50 5
2.5~5%
3
(
1-3
)
( TIA)
55
65
1.
(1.2~2.0mg/dl)
2.
(
240mg/dl
()
LDL 160mg/dl
1.5mg/dl)
300mg/day
50
HDL 40
45mg/dl
(
)
J Hypertension 2003;21:1984, WHO/ISH statement on hypertension
3
JNC7 120/80mmHg
140/90mmHg
2002
mmHg
140/90
1 130/80
g/d
1 g/d
125/75
20~25%
()
140-159 160-179
180
90-99mmHg 100-109mmHg 110mmHg
II 1-2
III()3
1.
0.5
1 mm-Hg
5-6mmHg40%10mmHg
2.
720cc300cc60cc
3.
4.
5.
6.
7.
8.
25~10
16
14
52.5
62.4
30%
10mmHg
5~6
3 ~5
1.
6
2.
(A)(B)
(C)
(1)
30g
15 mmHg710 mmHg
(2)
(licorice)carbenoxolone (
)
(mineralocorticosteroid)
(3)
(corticotropin, ACTH)
(4)
(nonsteroid anti-inflammatory drug,NSAID)
indomethacin
(5)
phenylpropanolamine
(catecholamine)
(MAO inhibitor)pargyline
(tyramine)
3.
4.
ductus arteriosus
5.
Conn's syndrome
ATP III
ATPIII)
()
CAD
55 65
45
55
140/90mmHg
()
()
() (target organ)
1.
(cyclosporine)(erythropoietin,
EPO)(MAO inhibitor)
9
2.
(1)
(2)
(3)
180/110mmHg/
30
3.
10
FriedwaldATPII
ATPIIIATPII1999chronic actable angina pectoris
LDLC
(1)
a.
Sokolow-LyonV5
V6RV1S35(mV)
QT
b.
c.
126mg%
/
d.
e.
T
f.
g.
11
(2)
a.
(3)
a.
(Doppler)
b.
12
(renin)
24
(catecholamine)
(norepinephrine)(epinephrine)
(dopamine)
13
1.
2.
3.
BB
1/4
ABC
720c.c.300c.c.60c.c.
B
()5 45
30%10mmHg
B
1. DThiazideThiazide-likeLoopPotassium-sparing agents
aldosterone-receptor blocker
2. ACE
3. ARB
4. CDihydropyridinenon-DHP(DiltiazemVerapamil)
15
5. Hydralazine(
)
6.
a. prazosin(
)
b.
PropranololNadolol(Corgard)Timolol
Atenolol.
LabetalolCarvedilol
7. O
ReserpineIsmelin
2 ClonidineMethyldopa
Carvedilol Clonidine
Carvedilol
C
1. 180/1101
130/802003 WHO/ISH
140/902004 BHS IVNICE2006
2. 160/1002 2004
BHS TVNICE2006
3. 1~2 140/90
2 (2003 WHO/ISH)
4. 140~159/90~992
140~149/90~94
140/90 (WHO/ISH)
2003 WHO/ISH
16
()
I.
(1)Thiazide diuretics
Chlorthalidone(G)
Hydrochlorothiazide(G)
Hygroton
Hydrodiuril
12.5-50 (1)
12.5-50 (1)
Indapamide
Metolazone
Dichlotride
Natrilix
Mykrox
1.25-2.5 (1)
0.5-1.0 (1)
(2)Loop diuretics
Bumetanide(G)
Ethacrynic acid
Furosemide(G)
Bumex Busix
Edecrin
Lasix
0.5-4 (2-3)
25-100 (2-3)
40-240 (2-3)
(3)Potassium-sparing agents
Amiloride hydrochloride(G)
Triamterene(G)
(4)Adosterone-receptor
blockers Spironolactone(G)
II.
(1)
Guanethidine monosulfate
Reserpine (G)
(2) 2
Clonidine hydrochloride(G)
Guanfacine hydrochloride(G)
Methyldopa(G)
(3)1
Prazosin hydrochloride(G)
Doxazosin mesytate
Terazosin hydrochloride
()
(,)
()
(,)
Midamor
Dyrenium
5-10 (1)
25-100 (1)
Aldactone
25-100 (1)
()
Ismelin
Serpasil
10-150 (1)
0.05-0.25 (1)
(:)
(,,)
Catapres
Tenex
Aldomet
0.2-1.2 (2-3)
1-3 (1)
500-3000 (2)
()
()
()
( prazosin)
Minipress
Doxaben
Hytrin
2-30 (2-3)
1-16 (1)
1-20 (1)
ISA
(4)
Propranolol hydrochloride(G)
Nadolol(G)
Timolol maleate(G)
(blood
dyscrasias)
Inderal
Corgard
Blocadren
10-480 (2)
40-320 (1)
20-60 (2)
17
Atenolol (G)
Betaxolol hydrochloride
Bisoprolol fumarate
Metoprolol tartrate(G)
Metoprolol succinate
Tenormin
Kerlone
Zebeta Concor
Betaloc
Toprol-XL
25-100 (1-2)
5-20 (1)
2.5-10 (1)
50-300 (2)
50-300 (1)
Sectral
Cartrol
Visken
200-800 (1)
2.5-10 (1)
10-60 (2)
Acebutolol
Carteolol hydrochloride
Pindolol (G)
(5)
Carvedilol
Labetalol hydrochloride (G)
III.
Dilatrend
Trandate
Apresoline
Loniten
12.5-50 (2)
200-1200 (2)
50-300 (2)
5-100 (1)
Cardizem SR
Cardizem CD
Isoptin SR
Verelan
120-360 (2)
120-360 (1)
90-480 (2)
120-480 (1)
Norvasc
Plendil
DynaCirc
Cardene SR
Procardia XL
Sular Syscor
2.5-10 (1)
2.5-20 (1)
5-20 (2)
60-90 (2)
30-120 (1)
20-60 (1)
()
()
V.
Benazepril hydrochioride
Captopril (G)
Enalapril maleate
Fosinopril sodium
Lisinopril
Moexipril
Quinapril hydrochloride
()
()
Lotensin
Capoten
Vasotec
Monopril
Prinivil, Zestril
Univasc
Accurpril
18
50-40 (1-2)
25-150 (2-3)
5-40 (1-2)
10-40 (1-2)
5-40 (1)
7.5-15 (2)
5-80 (1-2)
Ramipril
Trandolapril
VI.(ARB)
Altace
Mavik
Losartan potassium
Valsartan
Inbesartan
Telmisartan
Oimesartan
Camdesartan
Cozaar
Diovan
Aprovel
Micardis
Olmetec
Blopress
1.25-20 (1-2)
1-4 (1)
25-100 (1-2)
80-320 (1)
150-300 (1)
20-80 (1)
20-40 (1)
4-16 (1)
JAMA 2003;289:2565
ISA
19
ANTIHYPERENSIVE COMBINA COMBINATIONS TIONS IN TAIWAN
mg
Benazepril+ Hydrochlorothiazide
Captopril+ Hydrochlorothiazide
Cilazapril+ Hydrochlorothiazide
Enalapril+ Hydrochlorothiazide
Fosinopril+ Hydrochlorothiazide
Imidapril+ Hydrochlorothiazide
Lisinopril+ Hydrochlorothiazide
Moexipril+ Hydrochlorothiazide
4/1.25
Perindopril+ Indapamide
2/0.625
-
Quinapril+ Hydrochlorothiazide
-+
-+
II
+
BI
PRETERAX
PRETERAX
Benazepil+Amlodipine
Enalapril+Felodipine
Ramipril+Felodipine
Trandolapril+Verapamil
Atenolol+Chlorthalidone
100/25
SHPYNJA
TARGET
Bisoprolol+ Hydrochlorothiazide
Metoprolol+Chlorthalidone
Metoprolol+ Hydrochlorothiazide
Nadolol+Bendroflumethiazide
Pindolol+Clopamide
Propranolol(LA)+Hydrochlorothiazide
Timolol+Hydrochlorothiazide
Atenolol+Amlodipine
Atenolol+Nifedipine (SR)
Metoprolol+Felodipine
Candesartan+ Hydrochlorothiazide
Eprosartan+ Hydrochlorothiazide
Irbesartan+ Hydrochlorothiazide
150/12.5
COAPROVEL
Losartan+ Hydrochlorothiazide
Olmesartan medoxomil+
Hydrochlorothiazide
Telmisartan+ Hydrochlorothiazide
50/12.5
HYZAAR
40/12.5,80/12.5
MICARDIS
PLUS
20
Valsartan+ Hydrochlorothiazide
80/12.5,160/12.5 CO-DIOVAN
Amiloride+ Cyclopenthiazide
+Thiazide
/
Amiloride+ Hydrochlorothiazide
5/50
Spironolactone+Butizide(thiabutazide)
ALOZIDE
,
AMITON
,
AMIZIDE
MODURETIC
TIADEN
Spironolactone+ Hydrochlorothiazide
25/25
Spironolactone+Hydroflumethiazide
50/50
SLOSAT
,
,
,
ALDACTIDE
,
,
Triamterene+ Hydrochlorothiazide
50/25
Methyldopa+ Hydrochlorothiazide
ANJAL
DYAZIDE
TRIAZIDE
-
0.1/4
BEHYD RA
Reserpine+Chlorthalidone
Reserpine+Chlorothiazide
0.1/0.5/5
BRINERDIN
0.1/10/10
ESIDRI
RELAZIDE
0.1/25/15
LISEIPIN
Reserpine+Benzylhydrochlorothiazide
Reserpine+Dihydroergocristine+Clop
amide
Reserpine+Hydralazine+
Hydrochlorothiazide
Reserpine+ Hydrochlorothiazide
MINS
21
----------------------
A+CA+D A+C+D
22
1.
2.
atenolol
(head-to-head)
3. Cost-effective(LIFE
15%)()
80%
1.5~2
(1)(2)(3)
(4)
a.1997 JNC6
5.
6.
B
7. ACE
ARB ACE D
8.
ACE ( Renin- angiotensin )
ARB
23
9.
10.
Thiazide
1. 1997 JNC6 HCTZ 6.25mg~ 2.5mg
2. 2003JNC7Thiazide
JNC6?JNC7
3. 2003 WHO/ISH
4. 2004 BHS IV HCTZ 12.5mg
HCTZ JNC7
TZ 12.5mg HCTZ
28% 16
Indapamide
JNC7 JNC7
2003 JNC7 2002 ALLHAT
24
1. CAD B + C
A
CHF D
+ A +
C FelodipineAmlodipine
DM
A C2003JNC7
CVD D A
BPH -blocker
2.A+C A+D()
3.A+C+D()
A AC
A ACE ARB
B
C
D
JNC7,2003
25
- ACE
ARB CCB
ACC/AHA
MERIT-HF
COPERNICUS CIBIS
BHATSAVECapricom
EPHESUS
ALLHATHOPEANBP2
LIFECONVINCE
NKF-ADA ; UKPDS
ALLHAT
NKF ; Captopril
RENAALINDNTREIN
AASK
PROGRESS
JNC7 JAMA 2003,289:2568
AASKACC/AHA /ACE
AIRE Ramipril ALLHAT
ANBP2ARBBHAT-
CCBCIBIS Bisoprolol CONVINCE
Onset Verapamil COPERNICUSCarvedilol
EPHESUSEplerenone HOPE
IDNTInbesartan LIFE Losartan
MERIT-HF Metroprolol CR/XL
NKF-ADA-PROGRESSPerindopril
RALES Aldactone REIN Ramipril RENAAL
Losartan SAVE
SOLVDTRACETrandolapril UKPDS
ValHEFTValsartan
[2]
26
1.39
2.JNC7 JNC7
2003
WHO/ISH 2003
2004 BHS IV WHO/ISH BHS IV
25mg Hydrochlorothiazide
JNC7 ALLHAT
3.JNC7
2004 WHO/ISH
2003 2004
BHS IV
non-Dihydropyridine
z1997 JNC6
z1999 WHO/ISH
(2003 JNC7TZ ()
(2003 WHO/ISH
(2003 ESH-ESC
(2004 BHS IV A(B) CD
(1) ()
D1. 12.5mgHCTZ
2.BHS IV2004
3. (JNC7)
C
TZ
()
(2) ()
55 A( B)(BHS IV2004NICE2006)
A ACE ARB
(B)
(B) 1.
2.
3.
4.ACE
D
ACE 15~20% 1.ARB
2.3. C ()
A(B)
1. CAD (B)
z CAD A C
z A
2. CAD (B)
z DM D
z DM non-DHP (B)
non-DHP Af wpw Vf
28
(1)
55
1.
2.
A+CA+D Indapamide
B+C CA+OB+A D
z B
zJNC7
(2)
55 ()
A+CA+DC+D D
D+OC+BC+O D
z-blocker
1.A+C+D DJNC6
2.A+B+C C
3.Thiazide A+C+O C
Othe others() Reserpine 0.25mg 1/2
1/4 GuanethidineClonidine-methyldopa (19992003 WHO/ISH)
29
1.A+B+C+D (-blocker
2. u Hyperaldosteronism
Spironolactone
3.80mg
z
z
z
adolsteronism pheochromocytoma
z
z(
(codeine)(erythropoietin)
(cyclosporins)(Nasal decongestants)
z
30
140/90mmHg
55
55 ()
or
A ACE ACE
ARB,
(B)
+ or +
+ +
2. 80 55
3.
1. Indapamide
WHO/ISH 1999
31
2.
3. Verapamil Diltiazem(
) VerapamilDiltiazem()
4. Verapamil
5. -blocker B
6. ACEI ARB A
7. ACEI ARB Spironolactone
8.
9. Prazosin
D Guanethidine (
)
20mmHg D
10.
1999 WHO/ISH B
11.(ED)
ED (1)-blocker (2) (3) A (4)-blocker ED
ED
ED
(1) Thiazides
Spironolactone
Acetazolamide
Amiloride
Chlorthalidone
Impotence
Decreased libido, and impotence
Decreased libido, and impotence
Decreased libido, and impotence
Decreased libido, and impotence
(2) -blocker
Propranolol, and Labetalol
Decreased libido, and impotence
(3) Sympatholytics
Methyldopa
Decreased libido, and impotence
Clonidine
Impotence, and ejaculatory dysfunction
Reserpine
Decreased libido, and ejaculatory dysfunction
Guanethidine
Ejaculatory dysfunction
12.
32
(1)()
(2)
Vioxx
Procaterol(meptin)meptin FDA
aspyrin C
Histamin
Histamin
15
anaphylatic shock
decadnon A
Bosmin
D NS
D
14 ACE
HyporeninemicHypoaldosteronicHyperkalemic Syndrome B
1. (Hyporenin)
2.
3.
4. ()
Intra-atrialIntra-nodal &
Intra-Ventricular conduction delaySine
wave
(1)
(2)A B
1. B
aspirin(75mg)
aspirin
33
HOT 50
aspirin
aspirin
aspirin
aspirin aspirin
aspirin
2.
/(CHO)
(TG)(1)(VLDL)(2)
(LDL)(3)(HDL)(TotalC)
(HDLC)(LDLC)(VLDLC.
TG/5)ATP III20
HDLCLDLCATP IIIATP IIATP II
LDLCFriedewaldLDLCTotalCHDLC
VLDLCTG/5LDLC1999Guideline for the
management of patients with chronic stable angina
Calculated LDL()TG400mg%LDLC
LDLC94~99%TG
LDLC
LDLCTotalCHDLC+LDLC+VLDLC
(TG/5)TGLDLC/HDLC
Friedewald2013
LDLC
LDLC
LDLC
FraminghamATP III
10~20%
20%100
10200~1
10%ATP IIIII
ATP
(1)(2)140/90mmHg(3)HDL40mg/dl
60mg/dl(4)
5565(5)4555
HDL40mg/dl
34
TC200mg/dl
TC240mg/dl
LDL-C 130mg/dl
160mg/d>
TC200mg/dl(
TC/HDL-C5
HDL-C40mg/dl
TG200mg/dl
LDL-C130mg/dl
200 mg/dl
240 mg/dl
130 mg/dl
160 mg/dl
200 mg/dl
160 mg/dl
100 mg/dl
150 mg/dl
150 mg/dl
TG200mg/dl
(TC/HDL-C
5HDL-C40mg/dl
TG
200~499mg/dl
HDL-C130mg/dl
500mg/dlfibric
(3)
()
*1. 2.45 3. 4.55
5. 6.HDL40mg% (
56)
ATP III
A.
(1)LDLC130mg/dl(CHO 200mg/dl)Statins
LDLC100mg/dlCHO 160mg/dl(2)
LDLC100~129mg/dlTGHDLfibric acid
LDLC24~48
35
LDLC
LDLCLDLC100mg/dl
B.
C.0~1
LDLC
130mg/dlLDLC160mg/dl
LDLC130mg/dlLDLC
160mg/dlCHO 240mg/dl
LDLC190mg/dl
ATP III
Statins
(GPT)33~12
Statins
Bile acid sequestrant Cholestyamine(Questran)
LDLC15~30%
TG200mg/dl
TG500mg/dlfibric acid
TG200~499mg/dlATP III
LDLCHDL
TG
HDLC40mg/dlTotal/HDLC5HDLC
3540535/40=4.384.38HDLC=TotalC
HDLC=LDLC+VLDLC (TG/5)ATP III
TG200mg/dlHDLC130mg/dl
ATP IIIHDLC130mg/dlLDLC100mg/dl
TG150/5TG200mg/dl0~1
ATP IIIHDLC
36
190mg/dlHDLC
()160mg/dl160mg/dl
TG200mg/dl
TG150mg/dlfibric aid
20~50
Nicotinic acidTG20~50%
/
TG(TG)
HDLCTG
TGTG
(fatty liver)VLDLC
(IDLC)50%LDLCVLDLC
HDLC
LDLC
LDLCNCEP
7%
LDLC
LDLC200(
300)
HDLCLDLC
3.
37
1 2 ACE-I ARB
1
125/75mmHg130/80mmHg
3 3
ACE-I ARB 2.5mg
Thiazide loop loop diuretics
4.
1.5 2
2
80%
2 2
insulin resistant stateSyndrome X
HDLC
ATP3
metabolic syndrome130/85 mmHg
(110mg/dl)(9080
)(150mg/dl)(40mg/dl)
ACE-I ARB
ARB
HOT
80mmHg
130/80mmHg
ACE-IARBThiazide
HbA1C7%
5.
38
ACE ARB
ACE ARB Hydralazine
minoxidilACE ARB
6.
(ISA )
()(ISA)ACE
ACE
aspirin
7.
Framingham ()
(idiopathic
dilated cardiomyopathy)ACE
/
ACE
(ARB )1
(CarvedilolBisoprolol Metoprolol)
()
ACE
ACE
Hydralazine Isosorbide
dinitrate ACE ARB Dihydropyridine
amlodipine
ACC/AHA Guidelines for themanagement of HF 2001Felodipine
ACE /Arch
Intern Med/Vol 157,Nov24,1997
8.
BP>140/90mmHg
10mmHg90mmHg
39
3 1
25mmHg 15mmHg
8-10%(300mg/
)1.
2.:pre-eclampsia
20 3.
170/110mmHg
()
nifedipine
labetalol hydralazinemagnesium sulfate
oxprenololpindololatenolol
labetalolmethyldopaprazosinhydralazine
nifedipine isradipineACE
II
40
9.
2002 Framingham 55
90
160/95mmHg 50%60
140/90mmHg 70%65
65%
JNC7 50 140 mmHg
80
(Baroreceptor)
7%20%
()
Dihydropyridine ACE
ARB
prazosinTamsulosin
15%
41
1. , , . . .
2. . .
3. . .
4. World Health Organization. The World Health Report 2002: Risks to
Health 2002. Geneva: World Health Organization
5. Psart BM, Manolio TA, Smith NL, Heckbert SR, Gotdiener JS, Burke GL,
et al. Time trends in high blood pressure control and the use of
antihypertensive medications in older adults. The Cardiovascular Health
Study. Arch Intern Med 2002; 162:2325-2332.
6. Primatesta P, Brookes M, Poulter NR. Improved hypertension
management and control. Results from the Health Survey for England
1998.Hypertension 2001; 38:827-832.
7. Blood Pressure Lowering Treatment Trialists Collaboration. Effects of
ACE inhibitors, calcium antagonists, and other blood-pressure-lowering
drugs. Lancet 2000; 356:1955-1964.
8. The Heart Outcomes Prevention Evaluation Study Investigators. Effects
of an angiotensin-converting-enzyme inhibitor, ramipril, on
cardiovascular events in high-risk patients. N Engl J Med 2000;
342:145-153
9. Progress Collaborative Group. Randomized trial of a perindopril based
regimen on blood pressure lowering among 6105 individuals with
previous stroke or transient ischaemic attack. Lancet 2001;
358:1033-1041.
10. PARS Collaborating Group. Post-stroke antihypertensive treatment
study. A preliminary result. Chin Med J [Engl] 1995; 108:710-717.
11. Parving HH, Lenhert H, Brochner-Mortensen J, Gomis R, Andersen S,
Arner P. Irbesartan in patients with type 2 diabetes and
Microalbuminuria Study Group. The effects of Irbesartan on the
development of diabetic nephropathy in patients with type 2 diabetes. N
Engl J Med 2001; 345:870-878.
12. Brenner BM, Cooper ME, de Zeeuw D, Keane WF, Mitch WE, Parving
HH, et al. for the RENAAL Study Investigators. Effects of Losartan on
renal and cardiovascular outcome in patients with type 2 diabetes and
nephropathy. N Engl J Med 2001; 345:861-869.
13. Lewis EI, Hunsicker LG, Clarke WR, Berl T, Pohl MA, Lewis JB, et al.
Renoprotective effect of the angiotensin-receptor antagonist Irbesartan
42
43